Study: NCT00536679

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK163090 Tablet, fasted
Description: GSK163090 will be available as 1 mg white coated round tablet. Each subject will receive a single, oral dose of the study medication on the morning of Day 1. The study drug will be administered with approximately 240 mL of water.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK163090 Tablet, fasted
Description: GSK163090 will be available as 1 mg white coated round tablet. Each subject will receive a single, oral dose of the study medication on the morning of Day 1. The study drug will be administered with approximately 240 mL of water.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK163090 Tablet, fasted
Description: GSK163090 will be available as 1 mg white coated round tablet. Each subject will receive a single, oral dose of the study medication on the morning of Day 1. The study drug will be administered with approximately 240 mL of water.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK163090 Tablet, fasted
Description: GSK163090 will be available as 1 mg white coated round tablet. Each subject will receive a single, oral dose of the study medication on the morning of Day 1. The study drug will be administered with approximately 240 mL of water.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK163090 Tablet, fasted
Description: GSK163090 will be available as 1 mg white coated round tablet. Each subject will receive a single, oral dose of the study medication on the morning of Day 1. The study drug will be administered with approximately 240 mL of water.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK163090 Tablet, fed
Description: GSK163090 will be available as 1 mg white coated round tablet. Each subject will receive a single, oral dose of the study medication on the morning of Day 1. The study drug will be administered with Food and Drug Administration (FDA) high fat breakfast.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK163090 Tablet, fed
Description: GSK163090 will be available as 1 mg white coated round tablet. Each subject will receive a single, oral dose of the study medication on the morning of Day 1. The study drug will be administered with Food and Drug Administration (FDA) high fat breakfast.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK163090 Tablet, fed
Description: GSK163090 will be available as 1 mg white coated round tablet. Each subject will receive a single, oral dose of the study medication on the morning of Day 1. The study drug will be administered with Food and Drug Administration (FDA) high fat breakfast.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK163090 Tablet, fed
Description: GSK163090 will be available as 1 mg white coated round tablet. Each subject will receive a single, oral dose of the study medication on the morning of Day 1. The study drug will be administered with Food and Drug Administration (FDA) high fat breakfast.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK163090 Tablet, fed
Description: GSK163090 will be available as 1 mg white coated round tablet. Each subject will receive a single, oral dose of the study medication on the morning of Day 1. The study drug will be administered with Food and Drug Administration (FDA) high fat breakfast.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK163090 Tablet, fed
Description: GSK163090 will be available as 1 mg white coated round tablet. Each subject will receive a single, oral dose of the study medication on the morning of Day 1. The study drug will be administered with Food and Drug Administration (FDA) high fat breakfast.